FDA Approves GSK's BLA for 5-in-1 Meningococcal Vaccine
Today, GSK announced the FDA has accepted for review a Biologics License Application (BLA) for its 5-in-1 meningococcal ABCWY (MenABCWY) vaccine, and the federal agency has provided a PDUFA action date for a decision on February 14, 2025.1 The vaccine …